Advancing Therapies that Restore the Normal Cell Death Process in Cancer & Other Diseases
A Leader in the Discovery and Development of Small Molecules that Disrupt Protein-Protein Interactions
Ascentage Pharma (6855.HK) founded in 2009, is a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, CHB, and age-related diseases. The company aims to discovery and development of innovative first- and best-in-class therapies to address unmet medical needs globally.
Targeting Key Regulatory Proteins
Global Clinical Trials
San Antonio, TX
San Diego, CA
Rochester, MN
Ann Arbor, MI
Cleveland, OH
Philadelphia, PA
Baltimore, MD
Beijing
Suzhou
Guangzhou
Nedlands, AU
Camperdown, AU